Novartis’ testing of canakinumab, which works by curbing inflammatory signaling in cells, for the seemingly unrelated use in lung cancer stems from an intriguing 2011 …
The world’s largest Molecular Biology Conference and Stem Cells gathering for the Research Community, Join the Genetics Conference at Copenhagen, Denmark on Aug13-15,2018. Molecular Biology …
Targeting cells involved in blood vessel formation could prevent the growth of the most common type of brain tumour. A type of highly malignant brain …
